Scott Michael Galovan - 01 Aug 2025 Form 3 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, Chief Financial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Scott M. Galovan pursuant to Power of Attorney filed herewith
Issuer symbol
AVNS
Transactions as of
01 Aug 2025
Net transactions value
$0
Form type
3
Filing time
22 Aug 2025, 14:40:41 UTC
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Galovan Scott Michael SVP, Chief Financial Officer 5405 WINDWARD PARKWAY, SUITE 100, ALPHARETTA /s/ Mojirade James, as attorney-in-fact for Scott M. Galovan pursuant to Power of Attorney filed herewith 22 Aug 2025 0002082926

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVNS Common Stock 111,009 01 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVNS Employee Stock Option (right to buy) 01 Aug 2025 Common Stock 580 $29.48 Direct F2
holding AVNS Employee Stock Option (right to buy) 01 Aug 2025 Common Stock 1,263 $36.74 Direct F3
holding AVNS Employee Stock Option (right to buy) 01 Aug 2025 Common Stock 1,096 $52.10 Direct F4
holding AVNS Employee Stock Option (right to buy) 01 Aug 2025 Common Stock 1,078 $43.59 Direct F5
holding AVNS Employee Stock Option (right to buy) 01 Aug 2025 Common Stock 1,527 $28.87 Direct F6
holding AVNS Employee Stock Option (right to buy) 01 Aug 2025 Common Stock 21,038 $15.24 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of these shares, 80,718 are represented by unvested time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. These TRSUs will vest as follows: (i) 7,821 on March 6, 2026; (ii) 3,235 on March 7, 2026; (iii) 12,225 on April 22, 2026; (iv) 13,661 on August 1, 2026; (v) 5,330 on March 6, 2027; (vi) 3,236 on March 7, 2027; (vii) 13,661 on August 1, 2027; (viii) 3,334 on March 7, 2028; and (ix) 18,215 on August 1, 2028. Each TRSU is the economic equivalent of one share of Common Stock.
F2 These options vested 30% on May 5, 2017, 30% on May 5, 2018, and 40% on May 5, 2019.
F3 These options vested 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020.
F4 These options vested 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021.
F5 These options vested 30% on May 8, 2020, 30% on May 8, 2021, and 40% on May 8, 2022.
F6 These options vested 30% on May 7, 2021, 30% on May 7, 2022, and 40% on May 7, 2023.
F7 These options will vest 30% on March 7, 2026, 30% on March 7, 2027 and 40% on March 7, 2028.